Natural Phosphorylation of CD5 in Chronic Lymphocytic Leukemia B Cells and Analysis of CD5-Regulated Genes in a B Cell Line Suggest a Role for CD5 in Malignant Phenotype-Reference-Cited by-同舟云学术

Natural Phosphorylation of CD5 in Chronic Lymphocytic Leukemia B Cells and Analysis of CD5-Regulated Genes in a B Cell Line Suggest a Role for CD5 in Malignant Phenotype

Published:2007-09-18 Issue:7 Volume:179 Page:4335-4344
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Gary-Gouy Hélène,Sainz-Perez Alexander,Marteau Jean-Brice,Marfaing-Koka Anne,Delic Jozo,Merle-Beral Hélène,Galanaud Pierre,Dalloul Ali

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference62 articles.

1. B-cell chronic lymphocytic leukemia cells express a surface membrane phenotype of activated, antigen-experienced B lymphocytes

2. Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia

3. Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells✪

4. Biology of Chronic Lymphocytic Leukemia

5. Studies of Leukocyte Kinetics in Chronic Lymphocytic Leukemia

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mice Overexpressing Wild-Type RRAS2 Are a Novel Model for Preclinical Testing of Anti-Chronic Lymphocytic Leukemia Therapies;Cancers;2023-12-12

2. Are we there yet? cellular therapies for cutaneous T cell lymphoma;Current Research in Translational Medicine;2023-04

3. An Optimized Single Nucleotide Polymorphism-Based Detection Method Suggests That Allelic Variants in the 3’ Untranslated Region of RRAS2 Correlate with Treatment Response in Chronic Lymphocytic Leukemia Patients;Cancers;2023-01-19

4. Real-world efficacy of DA-EPOCH-R/HD-MTX regimen in CD5-positive diffuse large B cell lymphoma: a single-institute analysis;Journal of Clinical and Experimental Hematopathology;2023

5. Harnessing the Potential of Chimeric Antigen Receptor T-Cell Therapy for the Treatment of T-Cell Malignancies: A Dare or Double Dare?;Cells;2022-12-08